Affiliation:
1. Department of Pediatrics, Division of Pediatric Infectious Diseases, State University of New York Downstate Medical Center, Brooklyn, New York, USA
Abstract
The
in vitro
activities of omadacycline, azithromycin, doxycycline, moxifloxacin, and levofloxacin were tested against 15 isolates of
Chlamydia pneumoniae
. The minimum inhibitory concentration at which 90% of the isolates of
C. pneumoniae
were inhibited by omadacycline was 0.25 μg/ml (range, 0.03 to 0.5 μg/ml).
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology
Reference8 articles.
1. Hammerschlag MR, Kohlhoff SA, Gaydos CA. 2014. Chlamydia pneumoniae, p 2174–2182. In Mandell GL, Bennett JE, Dolin R (ed), Principles and Practice of Infectious Diseases, 8th ed. Elsevier, Inc., Philadelphia, PA.
2. Treatment of chlamydial infections: 2014 update
3. Activity of omadacycline tested against Streptococcus pneumoniae from a global surveillance program (2014)
4. In Vitro
Activities of Omadacycline (PTK 0796) and Other Antimicrobial Agents against Human Mycoplasmas and Ureaplasmas
5. In VitroActivity of AZD0914, a Novel DNA Gyrase Inhibitor, against Chlamydia trachomatis and Chlamydia pneumoniae
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献